Data / Form D filings / CALECO PHARMA CORP.
CALECO PHARMA CORP.: Form D filings
CALECO PHARMA CORP., a biotechnology company in Long Valley, NJ, filed 6 Form D notices with the SEC between 2009 and 2011. The latest, on June 21, 2011, reports $60,000 sold of a $60,000 offering to 1 investor.
Find out what CALECO PHARMA CORP. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 59 East Mill Road, Building 4, Suite 201, Long Valley, NJ, 07853
- Phone
- (360) 306-1133
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1312402
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 21, 2011 | New notice | $60,000 | $60,000 | $0 | 1 | May 10, 2011 | sec.gov |
| Jun 21, 2011 | New notice | $43,750 | $43,750 | $0 | 1 | Aug 16, 2010 | sec.gov |
| Mar 1, 2010 | Amendment | $170,000 | $170,000 | $0 | 11 | Oct 5, 2009 | sec.gov |
| Mar 1, 2010 | New notice | $81,000 | $81,000 | $0 | 1 | Feb 15, 2010 | sec.gov |
| Oct 16, 2009 | New notice | $10,860 | $10,860 | $0 | 1 | Oct 6, 2009 | sec.gov |
| Oct 16, 2009 | New notice | $150,000 | $105,000 | $45,000 | 2 | Oct 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Francisco Javier Benedi Garcia | Director | |
| John Boschert | Executive Officer, Director | |
| Rolf G Horchler | Promoter | |
| Rudolf Javier Mauer | Promoter | |
| Perry G Augustson | Promoter | |
| James A Sandino | Director | |
| Luc Vanhal | Executive Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Jun 20, 2011 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CALECO PHARMA CORP. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.